Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14338848 | 0.93 | KDM4E (0.56) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL3626637 | 0.93 | TDP1 (0.79) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL6051881 | 0.92 | TDP1 (0.60) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL804182 | 0.91 | TDP1 (0.63) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL13749778 | 0.90 | TDP1 (0.58) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL7035522 | 0.90 | KDM4E (0.71) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| Hydrochloric Acid SCHEMBL28308406 | 0.89 | TDP1 (0.61) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL27630924 | 0.89 | TDP1 (0.56) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL6979275 | 0.89 | HSD17B10 (0.57) | TDP1MAPTSMN1; SMN2LIN28AKDM4E | |
| SCHEMBL15780036 | 0.89 | TDP1 (0.56) | TDP1MAPTSMN1; SMN2LIN28AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | claimed |
| CN-115385873-B | Continuous synthesis method of perfluoro-2, 3-epoxy-2-methylpentane | 山东华夏神舟新材料有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-115385873-A | Continuous synthesis method of perfluoro-2, 3-epoxy-2-methylpentane | 山东华夏神舟新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| EP-3307940-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| EP-3307941-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| US-10882745-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2021-01-05 | — | — | US | claimed |
| US-10815616-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2020-10-27 | — | — | US | claimed |
| US-20180362432-A1 | ISOTOPIC FLUORINATION AND APPLICATIONS THEREOF | THE TRUSTEES OF PRINCETON UNIVERSITY | 2018-12-20 | — | — | US | claimed |
| US-20180186634-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-07-05 | — | — | US | claimed |
| EP-3307941-A1 | OXIDATIVE METHOD | Catexel Technologies Limited (GB) | 2018-04-18 | — | — | EP | claimed |
| US-20180094384-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-04-05 | — | — | US | claimed |
| WO-2017106340-A1 | ISOTOPIC FLUORINATION AND APPLICATIONS THEREOF | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2017-06-22 | — | — | WO | claimed |
| WO-2016198891-A1 | OXIDATIVE METHOD | CHEMSENTI LIMITED (GB) | 2016-12-15 | — | — | WO | claimed |
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | disclosed |
| CN-115385873-B | Continuous synthesis method of perfluoro-2, 3-epoxy-2-methylpentane | 山东华夏神舟新材料有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-115385873-A | Continuous synthesis method of perfluoro-2, 3-epoxy-2-methylpentane | 山东华夏神舟新材料有限公司 | 2022-11-25 | — | — | CN | disclosed |
| US-7829342-B2 | composition including a complex of a metal, a tetradentate ligand, at least one ancillary ligand, and a counterion is used for selective sp3 C H bond oxidation; includes a N-heterocyclic-N,N'-bis(pyridyl)-ethane-1,2-diamine group or a N,N'-bis(heterocyclic)-N,N'-bis(pyridyl)-ethane-1,2-diamine group | THE BOARD OF TRUSTEES OF THE UNIVERSIY OF ILLINOIS (US) | 2010-11-09 | — | — | US | disclosed |
| US-7829342-B2 | composition including a complex of a metal, a tetradentate ligand, at least one ancillary ligand, and a counterion is used for selective sp3 C H bond oxidation; includes a N-heterocyclic-N,N'-bis(pyridyl)-ethane-1,2-diamine group or a N,N'-bis(heterocyclic)-N,N'-bis(pyridyl)-ethane-1,2-diamine group | THE BOARD OF TRUSTEES OF THE UNIVERSIY OF ILLINOIS (US) | 2010-11-09 | — | — | US | disclosed |
| US-20090221083-A1 | Selective Aliphatic C-H Oxidation | BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090221083-A1 | Selective Aliphatic C-H Oxidation | BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221083-A1 | Selective Aliphatic C-H Oxidation | AOC3, SOD3, AP3S1 | TDP1 3179/4885MAPT 2961/4885SMN1; SMN2 3486/4885 |
| US-10815616-B2 | Oxidative method | CAT, LPO, MPO | TDP1 2935/4885MAPT 2450/4885SMN1; SMN2 1826/4885 |
| US-10882745-B2 | Oxidative method | CAT, LPO, GPX4 | TDP1 4126/4885MAPT 3440/4885SMN1; SMN2 4606/4885 |
| US-20180362432-A1 | ISOTOPIC FLUORINATION AND APPLICATIONS THEREOF | FTH1, SFXN3, SOD1 | TDP1 3999/4885MAPT 2906/4885SMN1; SMN2 1121/4885 |
| US-20180094384-A1 | OXIDATIVE METHOD | CAT, LPO, MPO | TDP1 2935/4885MAPT 2450/4885SMN1; SMN2 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.